New Inpatient Visitor Check-In Process Effective March 10. Learn more here.
Breadcrumb
- Home
- Clinical Care
- Departments
- Clinical Departments
- Hematology/Oncology
- Immunotherapy
- Checkpoint Inhibitors
Checkpoint Inhibitors
Checkpoint inhibitors enable the body’s own immune system to recognize and destroy cancer cells. Immune system T cells are designed to detect and fight infections and diseases like cancer. They attack when they come across a cancer cell. Tumor cell secrete a substance which inhibits the immune system from attacking it, allowing them to thrive. Checkpoint inhibitors disrupt this process, unleashing the T cells on cancer.
Checkpoint inhibitors are used to treat many different cancers, typically those that have metastasized. Among them are melanoma, non-small cell lung cancer, kidney cancer, bladder cancer, Hodgkin's lymphoma, and some head and neck cancers. Checkpoint inhibitors are sometimes combined to boost their power.
Share
-
Share with Facebook
-
Share with twitter
-
Share with email
-
Print this